Lorundrostat, an experimental drug, may help lower blood pressure in people with uncontrolled hypertension, researchers ...

CHICAGO -- Semaglutide further solidified its efficacy for diabetes-associated cardiovascular conditions, this time building ...

Colorado regulators are issuing licenses for providing psychedelic mushrooms and are planning to authorize the state's first ...

Jyong Biotech Ltd. (Revived IPO) (MENS) is planning to raise $22 million in an initial public offering (IPO) on Thursday, April 3rd, IPO Scoop reports. The company plans to issue 2,700,000 shares at ...

Novo Nordisk has submitted a supplemental application to the FDA for Rybelsus 14 mg to lower cardiovascular risk in adults ...

Jyong Biotech Ltd. (Revived IPO) (MENS) expects to raise $22 million in an IPO on Thursday, April 3rd, IPO Scoop reports. The company will be issuing 2,700,000 shares at $7.50-$8.50 per share. The ...

Dr. Peter Marks, the FDA's top vaccine official, resigns amid pressure from Health Secretary Robert F. Kennedy Jr., ...

Late-breaking data showed almost all patients achieved normal blood clotting and vessel repair after bentracimab infusion.

Three months of dual antiplatelet therapy after PCI may safely balance thrombosis and bleeding risk in both patients with low ...

Injectable semaglutide has better bioavailability, researchers say, but the many patients who want an oral drug are an unmet ...

Intracavitary tumors, including those originating from the respiratory tract, gastrointestinal (GI) tract, and urinary tract, mainly consist of epithelial cancers sharing similar characteristics, such ...

The “neutral” trial, troubled by the COVID-19 pandemic, found that intensive medical therapy didn’t lower events in INOCA.